Abstract
Extracellular structural remodeling is the compensatory response of the tissue following pathological stage. Myocardial infarction, which leads to adverse remodeling, thinning of the ventricle wall, dilatation and heart failure, is one of the leading causes of death. Remodeling implies an alteration in the extracellular matrix and in the spatial orientation of cells and intracellular components. The extracellular matrix is responsible for cardiac cell alignment and myocardial structural integrity. Substances that break down the extracellular matrix, specialized proteinases as well as inhibitors of proteinases, appear to be normally balanced in maintaining the integrity of the myocardium. Myocardial infarction leads to an imbalance in proteinase/ antiproteinase activities causing alterations in the stability and integrity of the extracellular matrix and adverse tissue remodeling. To explore mechanisms involved in this process and, in particular, to focus on matrix metalloproteinases, their inhibitors, and activators, an understanding of proteinase and antiproteinase is needed. This review represents new and significant information regarding the role of activated matrix proteinases antiproteinases in remodeling. Such information will have a significant impact both on the understanding of the basic cell biology of extracellular matrix turnover, as well as on potential avenues for pharmacological approaches to the treatment of ischemic heart disease and failure.
References
Borg TK, Burgess ML: Holding it all together: organization and function (s) of the extracellular matrix of the heart. Heart Failure 8: 230–238, 1993
Tyagi SC, Bheemanathini V, Mandi D, Reddy HK, Voelker DJ: Role of extracellular matrix in cardiac remodeling. Heart Failure Reviews 1: 73–80, 1996
Weber KT, Sun Y, Tyagi SC, Cleutjens J: Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279–292, 1994
Factor SM, Robinson TF: Comparative connective tissue structure-function relationships in biologic pumps. Lab Invest 58: 150–156, 1988
Royce PM, Steinmann B (eds). Connective Tissue and Its Heritable Disorders. Molecular Genetic, and Medical Aspects. Wiley-Liss Inc., New York, 1993
Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121–5, 1990
Alexander CM, Werb Z: Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1: 974–982, 1989
Laurent GJ: Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 252: C1–C9, 1987
Brilla CG, Janicki JS, Weber KT: Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 69: 107–115, 1991
Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ: Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 155: 13–21, 1996
Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ: Proteinases and restenosis in human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116: 43–57, 1995
Sato S, Ashraf M, Millard RW, Fujiwara H, Schwartz A: Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J Mol Cell Cardiol 15: 261–75, 1983
Graf J, Iwamoto M, Martin GR, Kleinman HK, Robey FA, Yamada Y: Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 48: 989–996, 1987
Eghbali M, Tomek R, Woods C, Bhambi B: Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effects of TGFβ. Proc Nat Acad Sci (USA) 88: 795–799, 1991
Zak R: Cell proliferation during cardiac growth. Am J Cardiol 31: 211–219, 1973
Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED: Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 6: H461–H468, 1979
Neurath H: Evolution of proteolytic enzymes. Science 224: 350–357, 1984
Tang J, Evolution in the structure and function of carboxyl proteases, Mol Cell Biochem 26: 93, 1979
Tyagi SC: Inhibitors of HIV-1 protease. Biochem & Cell Biol 70: 309–315, 1992
Khosla MC, Page IH, Bumpus FM: Interrelations between various blood pressure regulatory systems and the mosaic theory of hypertension. Biochem Pharmacol 28: 2867, 1979
Waterlow Jc, Garlick PJ, Millward DJ: Protein Turnover in Mammalian Tissues and the Whole Body. North-Holland Amsterdam, 1978
Schwartz MK, 1995, Tissue cathepsin as tumor marker. Clin Chim 237: 67–78, 1995
Wallin M, Deinulll J, Goobar L, Danielson UH: Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases. J Gen Virol 71: 185–191, 1990
Goldspink DF, Lewis SEM: Age and activity related changes in three proteinase enzymes of rat skeletal muscle. Biochem J 230: 833–836, 1985
Barrett AJ: An introduction to the proteinases. In: AJ Barrett and G Salvesen (eds). Proteinases Inhibitors. Elsevier Science Publishers, Amsterdam, 1986, pp 3–22
Kirschke H, Barrett AJ: The chemistry of lysosomal proteases. In: H Glaumann and FJ Ballard (eds). Lysosomes: Their Role in Protein Breakdown. Academic Press, New York, 193–238, 1987
Eeckhout Y, Vaes G: Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of Iysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 166: 21–31, 1977
Carrell RW, Travis J: A family of serpin. Trends Biochem Sci 10: 20, 1985
Tyagi SC, Simon SR: Inhibitors directed to binding domain in neutrophil elastase. Biochemistry 29: 9970–9977, 1990
Bieth JG: In: RP Mecham (ed). Biology of Extracellular Matrix: Regulation of Matrix Accumulation. Academic Press, Orlando, FL, 1986, pp 217–320
Capodici C, Muthukumaran G, Amoruso MA, Berg RA: Activation of neutrophil collagenaase by cathepsin G. Inflammation 13: 245–258, 1989
Reddi AH, Extracellular matrix and development. In: KA Piez and AH Riddi (eds). Extracellular Matrix Biochemistry. New York, Elsevier, 1984, pp 375–412
Grillo HC, Gross J: Collagenolytic activity during mammalian wound repair. Dev Biol 15: 300–317, 1967
Eisen AZ: Human skin collagenase: localization and distribution in normal human skin. J Invest Dermatol 52: 442–8, 1969
Blair HC, Teitelbaum SL, Ehlich LS and Jeffrey JJ: Collagenase production by smooth muscle: Correlation of immunoreactive with functional enzyme in the myometrium. J Cell Physiol 129: 111–123, 1986
Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–36, 1991
Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB: Mechanisms of matrix degradation in rheumatoid artheritis. Ann NY Acad Sci 580: 340–354, 1990
Roe JL, Farach HA Jr, Strittmatter WJ, Lennarz WJ: Evidence for involment of metalloproteinases in a step in sea urchin gamate fusion. J Cell Biol 107: 539–544, 1988
Gross J, Nagai Y: Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci (USA) 54: 1197–1204, 1965
Welgus HG, Jeffrey JJ, Stricklin GP, Eisen AZ: The gelatinolytic activity of human skin fibroblast collagenase. J Biol Chem 257: 11534–11539, 1982
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seilki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61–65, 1994
Henriet P, Rousseau GG, Eeckhout Y, Cloning and sequencing of mouse collagenase cDNA. FEBS 310: 175–178, 1992
Quinn CO, Scott DK, Brinckoff CF, Matrisian LM, Jeffrey JJ, Partridge NC, Rat Collagenases: Cloning amino acid sequence camparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 265: 22342–22347, 1990
Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145–2154, 1991
McKerrow JH: Human fibroblast collagenase contains an amino acid sequence homologous to the zinc-binding site of Serratia proteinase. J Biol Chem 262: 5943, 1987
Emmert-Buck MR, Emoilard HP, Corcoran ML, Krutzsch HC, Foidart JM, Stetler-Stevenson WG: Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett 364: 28–32, 1995
Fields GB, Netzel-Arnett SJ, Windsor LJ, Engler JA, Birkdal-Henson H, van Wart HE: Proteolytic activities of human fibroblast collagenase: Hydrolysis of a broad range of substrate at a single site. Biochemistry 29: 6670–6677, 1990
Hasty AK, Pourlllotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL: Human neutrophil collagenase: A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265: 11421–11424, 1990
Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identified to that secreted by normal human macrophages. J Biol Chem 264: 17213–17221, 1989
Werb Z: In: WN Kelley, ED Harris, S Ruddy, CB Sledge (eds). Textbook of Rheumatology. 3rd ed, Saunders WB, Philadelphia, 1989, pp 300–321
Gadher SJ, Eyre DR, Duance VC, Wotton SF, Heck LW, Schmid TM, Woolley DE: Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase. Eur J Biochem 175: 1–7, 1988
Tryggvason K, Hoyhtya M, Salo T: Proteloytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191–217, 1987
Werb Z, Hembry RM, Murphy G, Aggeller J: Commitment to expression of the metalloproteinases, collagenase and stromelysin: Relationship to inducing and to change in cytoskeletal architecture. J Cell Biol 102: 689–702, 1986
Nagase H, Enghild JJ, Suzllki K, Salvesen G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 29: 5783–9, 1990
Matrisian LM, Hogan BL, Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Develop Biol 24: 219–259, 1990
Okamura K, Sato Y, Matsuda T, Hamanaka R, Ono M, Kohno K, Kuwano M: Endodenous basic fibroblasts growth factor-dependent induction of collagenase and interleukin-6 tumor necrosis factor-treated human microvascular endothelial cells. J Biol Chem 266: 19162–19165, 1991
Dayer JM, Roelke MS, Krane SM: Effects of PGE2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Biochem Pharmacol 33: 2893–2899, 1984
Fisher WD, Golds EE, van der Rest M, Cooke TD, Lyons HE, Poole AR: Stimulation of collagenase secretion from rheumatoid synovial tissue by human collagen peptides. J Bone Joint Surg. Americam Volume 64: 546–557, 1982
Tyagi SC, Kumar SG, Alla SR, Reddy HK, Voelker DJ, Janicki JS: Extracellular matrix regulation of metalloproteinase and antiproteinase. in human heart fibroblast cells. J Cell Physiol 167: 137–147, 1996
Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by TNF-α. Nature (London) 337: 661–663, 1989
Yang-Yen, HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M: Transcriptional interference between c-Jun and the gluocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205–1215, 1990
Schule R, Rangarajan P, Kllewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM: Functional antogonism between oncoprotein cjun and the glucocorticoid receptor. Cell 62: 1217–1226, 1990
Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE: Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a ‘cystein switch’ mechanism for activation. Proc Natl Acad Sci USA 87: 364–8, 1990
Tyagi SC, Ratajska A, Weber KT: Myocardial matrix metalloproteinases: activation and localization. Mol Cell Biochem 126: 49–59, 1993
Lyons RM, Gentry LE, Purchio AF, Moses HL: Mechansim of activation of latent recombinant TGF-β by plasmin. J Cell Biol 110: 1361–1367, 1990
Lennarz WJ, Strittmatter WJ: Cellular functions of metallo-endoproteinases. Biochim Biophys Acta 1071: 149–158, 1991
Walakovits LA, Moore VL, Bharadwaj N, Gallick GS, Lark MW: Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis and Rheumatism 35: 35–42, 1992
Flenniken AM, Wiliams BRG: Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev 4: 1094–1106, 1990
Gavrilovic J, Hembry RM, Reynolds JJ, Murphy G: Tissue inhibitor of metalloproteinases (TIMPs) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J Cell Sci 87: 357–362, 1987
Okada Y, Watanabe S, Nakanishi I, Kishi J, Hayakawa T, Watorek W et al.: Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 229: 157–60, 1988
Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of TIMP-1 for a wide range of cells. FEBS Lett 298: 29–32, 1992
Tyagi SC, Meyer L, Kumar SG, Schmaltz RA, Reddy HK, Voelker DJ: Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Canad J Cardiol 12: 353–362, 1996
Leco, KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR: Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352–9360, 1994
Unemori EN, Boullana K, Werb Z: Vectorial secretion of extracellular matrix proteins, matrix degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem 265: 445–451, 1990
Gross J, Lapiere CM: Collagenolytic activity in amphibian tissue. Proc Natl Acad Sci (USA) 48: 1014–1022, 1962
Roe TL, Lennarz WJ: Biosynthesis and secretion of the hatching enzyme during sea urchin embryogenesis. J Biol Chem 265: 8704–8711, 1990
Blood CH, Zetter BR: Vasculature, angiogenesis and tumor metastasis. Biochem Biophys Acta 1032: 89–118, 1990
Woessner JE Jr, Morioka N, Zhu C, Mukaida T, Butler T, LeMaire WJ: Connective tissue breakdown in ovulation. Steroids 54: 491–499, 1989
Delaise JM, Eeckhout Y, Sear C, Galloway A, McCullagh K, Vaes G: A new synthetic inhibitor of mammalian tissue collagenases inhibits bone resorption in culture. Biochem Biophys Res Commun 133: 483–490, 1985
Tyagi SC, Matsubara L, Weber KT: Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191–198, 1993
Tyagi SC, Kumar SG, Glover G: Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 58: 360–371, 1995
Tyagi SC, Kumar SG, Borders S: Reduction-oxidation (Redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells. J Cell Biochem 61: 139–147, 1996
Bonnin CM, Sparrow MP, Taylor RR: Collagen synthesis and content in right ventricular hypertrophy in the dog. Am J Physiol 10: H703–H713, 1981
Charney RH, Takahashi S, Zhao M, Sonnenblick EH, Eng C: Collagen loss in the stunned myocardiuln. Circulation 85: 1483–1490, 1992
Montfort I, Perez-Tamayo R: The distribution of collagenase in normal rat tissues. J Histochem Cytochem 23: 910–20, 1975
Chakraborty A, Eghbali M: Collagenase activity in the normal rat myocardium: an immunohistochemical method. Histochemistry 92: 391–6, 1989
Woolley DE, Tetlow LC, Evanson JM: Collagenase immunolocalization studies of rheumatoid and malignant tissue. In: DE Woolley, JM Evanson (eds). Collagenases in Normal and Pathological Connective Tissues. John Wiley & Sons, New York, 1980, pp 103–125
Tyagi SC, Kulllar SG, Banks J, Fortson W: Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J Mol Cell Cardiol 27: 2177–2189, 1995
Tyagi SC, Kumar S, Cassatt S, Parker JL: Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in canine model of coronary occlusioll. Canad J Physiol and Pharmacol 74: 7–19, 1996
Williamson RA, Marston FAO, Angal S, Koklitis P, Panico M, Morris HR, Carne AF, Smith BJ, Harris TJR, Freedman RB: Disulfide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 268: 267–274, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tyagi, S.C. Proteinases and myocardial extracellular matrix turnover. Mol Cell Biochem 168, 1–12 (1997). https://doi.org/10.1023/A:1006850903242
Issue Date:
DOI: https://doi.org/10.1023/A:1006850903242